Diet Pills Market Size to Hit US$ 3.01 Billion By 2030| Grow at a CAGR of 9.8%, Growth Plus Reports

NEW YORK, Aug. 18, 2022 /PRNewswire/ — The Global Diet Pills market is expected to clock US$ 3.01 billion by 2030 owing to the rising prevalence of obesity and increased health awareness states Growth Plus Reports. This information is published in the latest report titled “Diet Pills Market – Global Outlook & Forecast 2022-2030″

Request a Sample Copy of the Research Report: https://growthplusreports.com/inquiry/request-sample/diet-pills-market/7744

Growth Drivers

Increasing cases of obesity and related health conditions, such as cardiovascular diseases (CVDs), diabetes, and high blood pressure are expected to drive the demand for diet pills. Increasing reliance on weight loss supplements to maintain normal body weight is expected to drive the growth of the market. Also, growing disposable income and rising concerns regarding maintaining a healthy lifestyle are expected to drive diet pills market growth. Government and private health organizations design and implement global programs and events to raise awareness of the obesity epidemic to promote the need to maintain nutritional health and normal body weight often by developing healthier eating habits and pursuing an active physical lifestyle.

The global diet pills market has been analyzed from three different perspectives – type, application, distribution channel, and region.

Excerpts from ‘By Product Type Segmentation’

The global diet pills market is segmented into two types:

• Over-The-Counter
• Prescription

The prescription drugs segment holds the largest market share. Weight loss pills are prescribed by medical professionals as a supplement to a weight loss regimen combined with exercise and a balanced diet. These prescribed diet pills are approved for long-term use and produce significant results. As a result, many obese people prefer to take medication as prescribed due to its authenticity and suitable recommended dosage. However, it has also been analyzed that the over-the-counter segment would be growing steadily in the forecast period because of the increased penetration of e-commerce and consumer knowledge.

Report Scope & Segmentation:

Purchase this Premium Report now: https://growthplusreports.com/checkout?_token=OJFteLBdsmSrLxFnoZWin3GFKGt6CAIv2Hv1Iyct&report_id=7744&license=Single

Excerpts from ‘By Application’

The global diet pills market is segmented into:

• Fat Blocking
• Appetite Suppression
• Others

The appetite suppression segment holds a large share of the diet pills market, owing to their effectiveness. They do not contain caffeine and other contents which increases their preference among the consumers. However, it has also been analyzed that the fat blockers segment is moderately rising among youngsters and women seeking quick aesthetic results and is mostly preferred by self-directed consumers.

Excerpts from ‘By Region Segmentation’

The global diet pills market has been segmented into:

• North America
• Europe
• Asia Pacific
• Rest of the World

It has been analyzed that North America dominated the diet pills market, owing to the high incidence of obesity, unhealthy food choices, sedentary lifestyle especially in the working class, and the presence of many key players marketing diet pills in this region. On the other hand, Europe is the second largest segment dominating the diet pills market. The presence of key regulatory approvals is one of the key factors responsible for this dominance. However, it has been observed that Asia Pacific is expected to experience a high growth rate in the forecast years owing to the rise in disposable incomes, and government initiatives to curb the incidence of obesity in order to reduce the disease burden on the economy. Key market players launching products in this region is also one of the reasons for the growth of the regional diet pills market.

Excerpts from ‘Competitive Landscape’

Some of the prominent players operating in the diet pills market are:

• Novo Nordisk A/S
• Gelesis
• Zoller Laboratories
• GlaxoSmithKline plc
• Chong’s Health Care
• Herbalife Limited
• Currax Pharmaceuticals LLC
• Arena Pharmaceuticals
• Nutrisystem Limited
• F. Hoffmann-La Roche Ltd
• Among others

Table of Content:

1. INTRODUCTION
1. Market Ecosystem 
2. Timeline Under Consideration
1. Historical Years – 2020
2. Base Year – 2021
3. Forecasted Years – 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources 
2. Primary Sources 
4. Market Estimation Approach
1. Bottom Up 
2. Top Down 
5. Market Forecasting Model
6. Limitations and Assumptions 
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021) 
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL DIET PILLS – ANALYSIS & FORECAST, BY PRODUCT TYPE
1. Over the Counter
2. Prescription 
6. GLOBAL DIET PILLS – ANALYSIS & FORECAST, BY APPLICATION
1. Fat Blocking
2. Appetite Suppression
3. Others 

TOC Continued.

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Speak to Our Expert: https://growthplusreports.com/inquiry/speak-analyst/diet-pills-market/7744

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.

Contact:
Manan Sethi Director, Market Insights
Email: [email protected]
Phone no: +91 96545 76783
Web: https://growthplusreports.com/ 
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1671244/Growth_Plus_Reports_Logo.jpg

SOURCE Growth Plus Reports